MiRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing

Journal of Neuroimmunology

Volumn 248, Issue 1-2, 2012, Pages 32-39

  Guerau de Arellano, Mireia ^a,b   Alder, Hansjuerg ^a   Ozer, Hatice Gulcin ^c   Lovett Racke, Amy ^a   Racke, Michael K ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

Autoimmunity; Biomarker; MiRNA; Multiple sclerosis; Neuroimmunology; Profiling

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

BIOGENESIS; BIOINFORMATICS; DISEASE ASSOCIATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TECHNOLOGY; HUMAN; MICROARRAY ANALYSIS; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; RNA ANALYSIS; RNA SEQUENCE; RNA SYNTHESIS; SEQUENCE ANALYSIS;

BIOLOGICAL MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; MOLECULAR BIOLOGY; MULTIPLE SCLEROSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEQUENCE ANALYSIS, RNA;

EID: 84859897019     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.10.006     Document Type: Review

References (64)

1. Allegretta M., et al. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science (New York, NY) 1990, 247(4943):718-721.
2. Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell 2003, 113(6):673-676.
3. Ambros V. The functions of animal microRNAs. Nature 2004, 431(7006):350-355.
4. Babak T., et al. Probing microRNAs with microarrays: tissue specificity and functional inference. RNA (New York, NY) 2004, 10(11):1813-1819.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
6. Bielekova B., Martin R. Development of biomarkers in multiple sclerosis. Brain J. Neurol. 2004, 127(Pt 7):1463-1478.
7. Calin G.A., et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(9):2999-3004.
8. Castoldi M., et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA (New York, NY) 2006, 12(5):913-920.
9. Chen C.-Z., et al. MicroRNAs modulate hematopoietic lineage differentiation. Science (New York, NY) 2004, 303(5654):83-86.
10. Chen C., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33(20):e179.
11. Cox M.B., et al. MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 2010, 5(8):e12132.
12. De Santis G., et al. Altered miRNA expression in T regulatory cells in course of multiple sclerosis. J. Neuroimmunol. 2010, 226(1-2):165-171.
13. Du C., et al. MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat. Immunol. 2009, 10(12):1252-1259.
14. Eis P.S., et al. Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(10):3627-3632.
15. Friedman R.C., et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19(1):92-105.
16. Geiss G.K., et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 2008, 26(3):317-325.
17. Giegerich G., et al. Diversity of T cell receptor alpha and beta chain genes expressed by human T cells specific for similar myelin basic protein/major histocompatibility complexes. Eur. J. Immunol. 1992, 22(5):1331.
18. Gregory R.I., et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005, 123(4):631-640.
19. Grimson A., et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27(1):91-105.
20. Guerau-de-Arellano, M. et al., in press. miRNA Dysregulation in Multiple Sclerosis Favors Pro-Inflammatory T Cell-Mediated Autoimmunity. Brain.
21. Hammond S.M., et al. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 2000, 404(6775):293-296.
22. Hutvágner G., et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science (New York, NY) 2001, 293(5531):834-838.
23. Jones M.R., et al. Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nat. Cell Biol. 2009, 11(9):1157-1163.
24. Junker A., et al. MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain J. Neurol. 2009, 132(Pt 12):3342-3352.
25. Katoh T., et al. Selective stabilization of mammalian microRNAs by 3' adenylation mediated by the cytoplasmic poly(A) polymerase GLD-2. Genes Dev. 2009, 23(4):433-438.
26. Keller A., et al. Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 2009, 4((10):e7440.
27. Ketting R.F., et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 2001, 15(20):2654-2659.
28. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 2005, 6(5):376-385.
29. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157. (Database issue).
30. Krek A., et al. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37(5):495-500.
31. Krichevsky A.M., et al. A microRNA array reveals extensive regulation of microRNAs during brain development. RNA (New York, NY) 2003, 9(10):1274-1281.
32. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
33. Lee Y., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425(6956):415-419.
34. Lee Y., et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004, 23(20):4051-4060.
35. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1):15-20.
36. Li Q.-J., et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007, 129(1):147-161.
37. Lim L.P., et al. Vertebrate microRNA genes. Science (New York, NY) 2003, 299(5612):1540.
38. Lindberg R.L.P., et al. Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur. J. Immunol. 2010, 40(3):888-898.
39. Lovett-Racke A.E., et al. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. J. Clin. Investig. 1998, 101(4):725-730.
40. Marques J.T., et al. Loqs and R2D2 act sequentially in the siRNA pathway in Drosophila. Nat. Struct. Mol. Biol. 2010, 17(1):24-30.
41. Martinez J., et al. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002, 110(5):563-574.
42. Mestdagh P., et al. High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA. Nucleic Acids Res. 2008, 36(21):e143.
43. Mestdagh P., et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009, 10(6):R64.
44. Meyer S.U., Pfaffl M.W., Ulbrich S.E. Normalization strategies for microRNA profiling experiments: a "normal" way to a hidden layer of complexity?. Biotechnol. Lett. 2010, 32(12):1777-1788.
45. Morin R.D., et al. Preparation and analysis of microRNA libraries using the Illumina massively parallel sequencing technology. Meth. Mol. Biol. (Clifton, NJ) 2010, 650:173-199.
46. Muljo S.A., et al. Aberrant T cell differentiation in the absence of Dicer. J. Exp. Med. 2005, 202(2):261-269.
47. Newman M.A., Mani V., Hammond S.M. Deep sequencing of microRNA precursors reveals extensive 3' end modification. RNA (New York, NY) 2011, 17:1795-1803.
48. Nuovo G.J. In situ detection of microRNAs in paraffin embedded, formalin fixed tissues and the co-localization of their putative targets. Methods (San Diego, Calif) 2010, 52(4):307-315.
49. Otaegui D., et al. Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 2009, 4((7):e6309.
50. Pauley K.M., Cha S., Chan E.K.L. MicroRNA in autoimmunity and autoimmune diseases. J. Autoimmun. 2009, 32(3-4):189-194.
51. Pelfrey C.M., et al. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production. J. Immunol. 2000, 165(3):1641-1651.
52. Petrocca F., Visone R., Onelli M.R., Shah M.H., Nicoloso M.S., de Martino I., Iliopoulos D., et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer cell 2008, 13(3):272-286. 10.1016/j.ccr.2008.02.013.
53. Place R.F., et al. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(5):1608-1613.
54. Rothberg J.M., Leamon J.H. The development and impact of 454 sequencing. Nat. Biotechnol. 2008, 26(10):1117-1124.
55. Shendure J., et al. Advanced sequencing technologies: methods and goals. Nat. Rev. Genet. 2004, 5(5):335-344.
56. Tili E., et al. miRNAs and their potential for use against cancer and other diseases. Future Oncol. (Lond. Engl.) 2007, 3(5):521-537.
57. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75(5):855-862.
58. Wyman S.K., et al. Post-transcriptional generation of miRNA variants by multiple nucleotidyl transferases contributes to miRNA transcriptome complexity. Genome Res. 2011, 21:1450-1461.
59. Xiao C., et al. Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat. Immunol. 2008, 9(4):405-414.
60. Yang J.-S., et al. Widespread regulatory activity of vertebrate microRNA* species. RNA (New York, NY) 2011, 17(2):312-326.
61. Yi R., et al. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 2003, 17(24):3011-3016.
62. Zeng Y., Cullen B.R. Sequence requirements for micro RNA processing and function in human cells. RNA (New York, NY) 2003, 9(1):112-123.
63. Zeng Y., Yi R., Cullen B.R. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2003, 100(17):9779-9784.
64. Zhou X., et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J. Exp. Med. 2008, 205(9):1983-1991.